Serial entrepreneur and operator focused on growth-stage technology companies, with experience building go-to-market teams, product-led growth, and scaling SaaS and marketplace models. Byron Gustus combines founder experience with angel and seed investing, serving on several private company boards and advising venture-backed management teams. Market-relevant strengths include revenue scaling, customer acquisition strategy, capital raises and exit preparation for strategic or acquisition outcomes.
Serial entrepreneur and operator focused on growth-stage technology companies, with experience building go-to-market teams, product-led growth, and scaling SaaS and marketplace models. Byron Gustus combines founder experience with angel and seed investing, serving on several private company boards and advising venture-backed management teams. Market-relevant strengths include revenue scaling, customer acquisition strategy, capital raises and exit preparation for strategic or acquisition outcomes.
Combines founder-operator sensibilities with pragmatic early-stage investing, prioritizing growth-stage tech companies where product-led distribution and repeatable SaaS or marketplace unit economics are emerging. Focuses on capital-efficient revenue scaling, go-to-market motion optimization, and customer acquisition channels that demonstrate scalable CAC payback. Prefers lead or active seed/angel positions that allow board or adviser proximity to influence hiring, metrics discipline, and fundraising cadence. Investment horizon spans 3–7 years with exit-oriented playbooks; risk managed through concentration in core sectors, hands-on operational support, milestone-based follow-ons, and disciplined cap allocation tied to growth inflection points.
Combines founder-operator sensibilities with pragmatic early-stage investing, prioritizing growth-stage tech companies where product-led distribution and repeatable SaaS or marketplace unit economics are emerging. Focuses on capital-efficient revenue scaling, go-to-market motion optimization, and customer acquisition channels that demonstrate scalable CAC payback. Prefers lead or active seed/angel positions that allow board or adviser proximity to influence hiring, metrics discipline, and fundraising cadence. Investment horizon spans 3–7 years with exit-oriented playbooks; risk managed through concentration in core sectors, hands-on operational support, milestone-based follow-ons, and disciplined cap allocation tied to growth inflection points.
| Trades 790 | Longs Won 574/790 72% | Profit Factor 12.31 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $479,700.48 |
| Average Win $139,056.14 | Best Trade (Aug 17) $9.89M | Sharpe Ratio -13.57 |
| Average Loss -$30,027.89 | Worst Trade (Sep 01) -$835,770.01 | Z-Score 17.35 (100%) |
| Commissions $0 | Avg. Trade Length 9m 2d | Expectancy $92,821.37 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 7,813 | 7,031 | 6,250 | 5,469 | 4,688 | 3,906 | 3,125 | 2,344 | 1,563 | 781 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 19,752 | $5.04M | $6.14M | - | $1.1M | 21.93% | +0.524% |
ABBV AbbVie Inc. | 13,222 | $2.58M | $3.22M | - | $643,795.76 | 24.96% | 0.0 |
AEP American Electric Power Company, Inc. | 3,047 | $334,792.38 | $385,354.09 | - | $50,561.71 | 15.1% | -1.465% |
AGNCO AGNC Investment Corp. 10.1219% Perpetual Preferred Stock | 101,142 | $2.56M | $2.58M | - | $20,796.4 | 0.81% | -0.078% |
AIQ Global X Artificial Intelligence & Technology ETF | 7,089 | $373,224.65 | $429,380.73 | - | $56,156.08 | 15.05% | -4.055% |
ALL Allstate Corporation | 4,992 | $964,909.33 | $1.31M | - | $345,790.19 | 35.84% | 0.0 |
AMAT Applied Materials, Inc. | 530 | $383,190 | $292,586.5 | - | -$90,603.5 | -23.64% | +0.993% |
AMD Advanced Micro Devices, Inc. | 4,091 | $743,372.35 | $2.12M | - | $1.38M | 185.39% | 0.0 |
AMGN Amgen Inc. | 4,743 | $1.34M | $1.85M | - | $509,226.02 | 37.98% | 0.0 |
AMZN Amazon.com Inc | 12,996 | $2.86M | $3.61M | - | $740,633.83 | 25.85% | 0.0 |
ANET Arista Networks, Inc. | 18,523 | $2.22M | $3.65M | - | $1.44M | 64.99% | +3.569% |
APLD Applied Digital Corporation | 8,967 | $216,131 | $267,844.29 | - | $51,713.29 | 23.93% | -4.477% |
ARCC Ares Capital Corporation | 171,613 | $3.67M | $3.22M | - | -$452,870.11 | -12.33% | -4.529% |
ASML ASML Holding N.V. New York Registry Shares | 928 | $990,224.6 | $1.56M | - | $567,163.56 | 57.28% | -1.967% |
AVGO Broadcom Inc. | 31,375 | $7.83M | $13.12M | - | $5.29M | 67.49% | 0.0 |
BAC Bank of America Corporation | 68,933 | $3.13M | $4.36M | - | $1.23M | 39.32% | +0.556% |
BG Bunge Global S.A. | 2,260 | $285,936.76 | $241,209.8 | - | -$44,726.96 | -15.64% | 0.0 |
BHLB Berkshire Hills Bancorp Inc | 7,574 | $227,319.48 | $230,634 | - | $3,314.52 | 1.46% | +1.505% |
BKR Baker Hughes Company | 6,391 | $375,663.2 | $394,516.43 | - | $18,853.23 | 5.02% | 0.0 |
BMY Bristol-Myers Squibb Company | 19,000 | $1.08M | $1.21M | - | $131,410.44 | 12.2% | -3.43% |